Sandoz Lays Out Plan For Rebound With Top Line Stagnant In 2021

Core Operating Profit Falls By 12% As Reported; 14% In Constant Currencies

 
• By Dean Rudge
  
sales surge
Novartis continues to plot a rebound for Sandoz • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business